Results 191 to 200 of about 157,645 (329)

Different clinical and genetic features of Alagille patients with progressive disease versus a jaundice‐free course

open access: yesJGH Open, Volume 6, Issue 12, Page 839-845, December 2022., 2022
This study highlighted the different disease courses of Alagille syndrome patients with progressive disease (PD) or the jaundice‐free (JF) courses based on clinical follow‐up. Patients in the JF group had a favorable outcome and longer native liver survival than the PD group.
Che‐Ming Chiang   +13 more
wiley   +1 more source

DDOST Mutations Identified by Whole-Exome Sequencing Are Implicated in Congenital Disorders of Glycosylation

open access: green, 2012
Melanie A. Jones   +11 more
openalex   +1 more source

Whole-Exome Sequencing Studies of Nonfunctioning Pituitary Adenomas [PDF]

open access: bronze, 2013
Paul Newey   +13 more
openalex   +1 more source

ESR1 Variants and Subcontinental Genomic Ancestry: Insights from the 1000 Genomes Project and Native American Populations

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The ESR1 gene is relevant in breast cancer treatments in the pharmacogenetics context. However, Native, African, and mixed populations are known to be underrepresented in genomic studies. This is particularly important given that the difference in variants' frequencies among different populations can lead to population‐specific clinical implications ...
Mariana M. Scudeler   +11 more
wiley   +1 more source

Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease [PDF]

open access: green, 2013
Karen Nuytemans   +11 more
openalex   +1 more source

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
There is increasing attention on the clinical utility and value of pharmacogenetic (PGx) testing to individualize medication management. Most clinical practice guidelines from medical professional societies do not recommend routine PGx testing, with a few key exceptions.
James M. Stevenson   +4 more
wiley   +1 more source

Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges

open access: gold, 2012
Kerstin Knies   +6 more
openalex   +2 more sources

Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis. Clonal haematopoiesis and heart failure: a meta‐analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure. [Correction added on 15 March 2025, after first online publication: The graphical image was corrected in ...
Paschalis Karakasis   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy